These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4574459)

  • 21. Components of the renin system. An update.
    Hsueh WA
    Am J Nephrol; 1983; 3(2-3):109-17. PubMed ID: 6346872
    [No Abstract]   [Full Text] [Related]  

  • 22. Renin and hypertension.
    Verniory A; Staroukine M; Delwiche F
    Brux Med; 1973 Nov; Spec No(0):63-86. PubMed ID: 4371909
    [No Abstract]   [Full Text] [Related]  

  • 23. [The control of renin secretion: experimental data and clinical implications].
    Zanchetti A; Leonetti G; Morganti A; Terzoli L; Stella A
    Atti Soc Ital Cardiol; 1978; 37():46-59. PubMed ID: 356832
    [No Abstract]   [Full Text] [Related]  

  • 24. [Angiotensin antagonists in the diagnosis and treatment of renin-dependent hypertension].
    Ganten D; Gross F
    Med Klin; 1976 Nov; 71(47):2043-50. PubMed ID: 794662
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of juxtagolmerular apparatus in renal allograft rejection.
    Varkarakis MJ; Murphy GP
    N Y State J Med; 1975 Mar; 75(4):529-34. PubMed ID: 1095976
    [No Abstract]   [Full Text] [Related]  

  • 26. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension.
    Mahmud A; Feely J
    Am J Hypertens; 2005 Jan; 18(1):50-5. PubMed ID: 15691617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Plasmatic renin activity in essential arterial hypertension. Hyporeninemic hypertension].
    Gutiérrez Millet V; Casado Pérez S; Ruilope Urioste LM; Hernando Avendaño L
    Rev Clin Esp; 1975 Apr; 137(2):105-14. PubMed ID: 1144838
    [No Abstract]   [Full Text] [Related]  

  • 28. Low-renin hypertension. Restoration of normotension and renin responsiveness.
    Spark RF; O'Hare CM; Regan RM
    Arch Intern Med; 1974 Feb; 133(2):205-11. PubMed ID: 4591266
    [No Abstract]   [Full Text] [Related]  

  • 29. Nitric oxide in the juxtaglomerular apparatus.
    Ito S; Carretero OA; Abe K
    Kidney Int Suppl; 1996 Jun; 55():S6-8. PubMed ID: 8743502
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
    J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Regulation of renin secretion. II. Integrating function of the juxtaglomerular apparatus].
    Rössler R; Klaus D
    Med Welt; 1973 Sep; 24(36):1356-9. PubMed ID: 4766290
    [No Abstract]   [Full Text] [Related]  

  • 32. Primary aldosteronism: the most frequent form of secondary hypertension?
    Shargorodsky M; Zimlichman R
    Isr Med Assoc J; 2002 Jan; 4(1):32-3. PubMed ID: 11802308
    [No Abstract]   [Full Text] [Related]  

  • 33. Pathophysiology of hypertension.
    Gantt CL
    Med Clin North Am; 1967 Jan; 51(1):3-14. PubMed ID: 4296521
    [No Abstract]   [Full Text] [Related]  

  • 34. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [High-dose spironolactone therapy in essential hypertension patients with low plasma renin].
    Distler A; Keim HJ; Lommer D; Philipp T; Philippi A; Walter U; Wolff HP
    Verh Dtsch Ges Inn Med; 1973; 79():770-3. PubMed ID: 4789984
    [No Abstract]   [Full Text] [Related]  

  • 36. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertension and hyperaldosteronism with low plasma renin concentration: analysis of a series of eighty-two patients.
    Brown JJ; Chinn RH; Düsterdieck GO; Fraser R; Gleadle RH; Lever AF; Robertson JI; Tree M
    Proc R Soc Med; 1969 Dec; 62(12):1258-60. PubMed ID: 5363111
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of spironolactone and indapamide in the treatment of low-renin arterial hypertension].
    Naudzhunas A; Bagdonas G; Yankauskene L; Kazanavichus G
    Ter Arkh; 2006; 78(2):61-4. PubMed ID: 16613101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Structural foundation for the functional connections of the endocrine apparatus and nervous system of the kidneys].
    Serov VV; Pal'tsev MA
    Arkh Patol; 1978; 40(11):3-11. PubMed ID: 367331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma renin activity in the diagnosis of primary aldosteronism: failure to distinguish primary aldosteronism from essential hypertension.
    Jose A; Kaplan NM
    Arch Intern Med; 1969 Feb; 123(2):141-6. PubMed ID: 5812600
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.